RedShift BioAnalytics nets $18 mn
Burlington, Massachusetts-based RedShift BioAnalytics Inc, a provider of analytical instrumentation for the research, development and manufacture of protein therapeutic drugs, has raised $18 million in funding.
Burlington, Massachusetts-based RedShift BioAnalytics Inc, a provider of analytical instrumentation for the research, development and manufacture of protein therapeutic drugs, has raised $18 million in funding.
Copyright PEI Media
Not for publication, email or dissemination